It is postulated that CDK6 drives MLL-AF9-mediated disease by inhibiting myeloid differentiation based on the observation that small hairpin RNA (shRNA)-mediated depletion of CDK6 induced myeloid differentiation in MLL-rearranged (MLLr) AML cells. Here, KMT2A is linked to acute myeloid leukemia.